Filtered By:
Condition: Chronic Obstructive Pulmonary

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 1666 results found since Jan 2013.

Causal relationship between asthma-related diseases and the risk of COVID-19: A  2-sample mendelian randomization study
We read with interest the study recently published by Skevaki et  al1 in the Journal of Allergy and Clinical Immunology. Skevaki et al1 found that the differences in risk associated with coronavirus disease 2019 (COVID-19) that are observed in patients with asthma are associated with different prevalence of underlying comorbidities, particularly, chronic obstru ctive pulmonary disease (COPD). However, inconsistent associations between asthma and COVID-19 disease have been observed in epidemiology studies.
Source: Journal of Allergy and Clinical Immunology - July 10, 2023 Category: Allergy & Immunology Authors: Shu Ran, XinHong Qiu, BaoLin Liu Tags: Correspondence Source Type: research

Parsing the Split-Decision Victory for Biologics in COPD Parsing the Split-Decision Victory for Biologics in COPD
A single drug that works for COPD exacerbations would be welcome news, but studies of new monoclonal antibodies conflict, and Dr Aaron Holley still has a lot of questions.Medscape Critical Care
Source: Medscape Allergy Headlines - July 6, 2023 Category: Allergy & Immunology Tags: Pulmonary Medicine Viewpoint Source Type: news

Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study
CONCLUSION: The role of INCS in COVID-19 is still unclear, but exposure to INCS does not adversely affect COVID-19 mortality. Further studies are needed to explore the association between their use and inflammatory activation, viral load, ACE2 gene expression, and outcomes, exploring different types and doses of INCS.PMID:37414336 | DOI:10.1016/j.anai.2023.06.026
Source: Annals of Allergy, Asthma and Immunology - July 6, 2023 Category: Allergy & Immunology Authors: Dr Virginia Hernandez Santiago Dr Adeniyi Francis Fagbamigbe Prof Frank Sullivan Dr Utkarsh Agrawal Dr Daniel Morales Prof Colin McCowan Prof Brian Lipworth Source Type: research

Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute coronavirus disease 2019 (COVID-19); however, little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Virginia Hernandez Santiago, Adeniyi Francis Fagbamigbe, Frank M Sullivan, Utkarsh Agrawal, Daniel Morales, Colin McCowan, Brian Lipworth Tags: Original Article Source Type: research

COPD and biologic treatment: state of the art
Curr Opin Allergy Clin Immunol. 2023 Jun 21. doi: 10.1097/ACI.0000000000000920. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Chronic Obstructive Pulmonary Disease (COPD) is a common, heterogeneous disease associated with abnormal inflammatory response of the lung to noxious particles and gases. The progression of disease leads to respiratory failure, disability and premature death. Although recent progress in reducing the global burden of many chronic disease, such as heart disease and cancer, mortality and morbidity due to COPD continue to increase despite of cigarette smoking worldwide policy. Additionally, diagnosti...
Source: Clinical Lung Cancer - June 26, 2023 Category: Cancer & Oncology Authors: Sebastian Ferri Giovanni Paoletti Corrado Pelaia Enrico Heffler Giorgio Walter Canonica Francesca Puggioni Source Type: research

Electronic Nose May Sniff Out Early Lung Cancer in COPD Electronic Nose May Sniff Out Early Lung Cancer in COPD
An electronic exhaled breath analyzer showed differences in breath profiles of patients with COPD who went on to develop lung cancer.Medscape Medical News
Source: Medscape Allergy Headlines - June 15, 2023 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients
(MedPage Today) -- WASHINGTON -- Treatment with the first-in-class dual phosphodiesterase 3/4 inhibitor ensifentrine reduced exacerbation rates and improved other key outcomes in patients with chronic obstructive pulmonary disease (COPD), according...
Source: MedPage Today Allergy - May 25, 2023 Category: Allergy & Immunology Source Type: news

In-Hospital Antibiotic Use for Severe COPD Exacerbations In-Hospital Antibiotic Use for Severe COPD Exacerbations
How often are in-hospital antibiotics used in severe COPD patients -- and what impact does this practice have on patient outcomes?BMC Pulmonary Medicine
Source: Medscape Allergy Headlines - May 24, 2023 Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs
(MedPage Today) -- Chronic obstructive pulmonary disease (COPD) patients starting on a combination maintenance inhaler had better outcomes if they were prescribed one containing a long-acting muscarinic antagonist and long-acting beta-agonist ...
Source: MedPage Today Allergy - May 23, 2023 Category: Allergy & Immunology Source Type: news

Dupilumab Reduces COPD Exacerbations
(MedPage Today) -- WASHINGTON -- Among chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation at high risk for exacerbations despite being on standard triple therapy, adding dupilumab (Dupixent) was associated with clinically...
Source: MedPage Today Allergy - May 22, 2023 Category: Allergy & Immunology Source Type: news

Dupilumab Curbs Acute COPD Exacerbations Dupilumab Curbs Acute COPD Exacerbations
Patients treated with dupilumab for COPD also showed significant improvements in lung function at 12 and 52 weeks.Medscape Medical News
Source: Medscape Allergy Headlines - May 22, 2023 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Identifying risk factors for COPD and adult-onset asthma: an umbrella review
Conclusions Many different factors for COPD and asthma have been found, highlighting the differences and similarities. The results of this systematic review can be used to target and identify people at high risk for COPD or AOA.
Source: European Respiratory Review - May 3, 2023 Category: Respiratory Medicine Authors: Holtjer, J. C. S., Bloemsma, L. D., Beijers, R. J. H. C. G., Cornelissen, M. E. B., Hilvering, B., Houweling, L., Vermeulen, R. C. H., Downward, G. S., Maitland-Van der Zee, A.-H., on behalf of the P4O2 consortium Tags: COPD and smoking, Asthma and allergy Reviews Source Type: research